Free Trial

UnitedHealth Group Incorporated $UNH Shares Sold by State of Wyoming

UnitedHealth Group logo with Medical background

Key Points

  • The State of Wyoming has reduced its stake in UnitedHealth Group by 38.7%, now holding 1,374 shares valued at approximately $720,000.
  • UnitedHealth Group reported $4.08 earnings per share for the last quarter, falling short of analysts' expectations of $4.45, with revenue reaching $111.62 billion.
  • The company has announced a quarterly dividend of $2.21 per share, representing an annualized dividend yield of 2.9%, with a payout ratio of 38.30%.
  • Five stocks we like better than UnitedHealth Group.

State of Wyoming trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 38.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,374 shares of the healthcare conglomerate's stock after selling 867 shares during the quarter. State of Wyoming's holdings in UnitedHealth Group were worth $720,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of UNH. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Royal Bank Of Canada cut their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $353.00.

Read Our Latest Analysis on UNH

UnitedHealth Group Price Performance

Shares of UNH traded up $7.48 during trading hours on Friday, hitting $309.77. 12,018,847 shares of the stock were exchanged, compared to its average volume of 18,891,168. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a market cap of $280.55 billion, a price-to-earnings ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.44. The stock's 50-day moving average price is $288.16 and its two-hundred day moving average price is $379.63.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's payout ratio is 38.30%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.28% of the company's stock.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines